ENVASARC: A pivotal trial of envafolimab, and envafolimab in combination with ipilimumab, in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy Meeting Abstract


Authors: D'Angelo, S. P.; Robinson, S. I.; Lam, J.; Adams, B. J.; Freddo, J. L.; Theuer, C. P.; Maki, R. G.
Abstract Title: ENVASARC: A pivotal trial of envafolimab, and envafolimab in combination with ipilimumab, in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120306172
DOI: 10.1200/JCO.2021.39.15_suppl.TPS11581
PROVIDER: wos
Notes: Meeting Abstract: TPS11581 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sandra Pierina D'Angelo
    252 D'Angelo